Skip to main content
Veterinary Medicines

Cephacare flavour 50 mg tablets for cats and dogs

Authorised
  • Cefalexin monohydrate

Product identification

Medicine name:
Cephacare flavour 50 mg tablets for cats and dogs
Cephacare Flavour 50 mg Tabletten für Katzen und Hunde
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    52.59
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Cephacare flavour 50 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 20 tablets.
  • Cephacare flavour 50 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 100 tablets.
  • Cephacare flavour 50 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboardboxes containing 250 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Produlab Pharma B.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401081.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0454/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 6/04/2025
Download
German (PDF)
Published on: 24/07/2025